Hypofractionated Radiotherapy for Nasopharyngeal Carcinoma

The purpose of this study was to evaluate the efficacy and safety of large fractionation radiotherapy in nasopharyngeal carcinoma patients, and to analyze whether Hypofractionated radiotherapy is not inferior to conventional radiotherapy.

Trial Details

NCT ID
NCT06796270
Phase
NA
Sponsor
The Second Affiliated Hospital of Hainan Medical University
Status
RECRUITING
Cancer Type
Nasopharyngeal Head and Neck Cancer
Interventions
  • Hypofractionated radiotherapy
Locations (sample)
  • Haikou, Hainan, China|20.03421,110.34651

Key Eligibility Criteria

  • Age 18-75 years, male or female；
  • Performance status ≤ 2 ;
  • Nasopharyngeal cancer patients diagnosed by pathology (including histology or cytology) , of nasopharyngeal non-keratonic carcinoma (differentiated…
  • Have at least one evaluable lesion (according to Recist1.1 criteria)

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Nasopharyngeal Head and Neck Cancer Trials on Trialify →